Last edition
News about "APOL1-mediated kidney disease"
Vertex Reports Positive Phase 2b AMPLIFIED Study Results
Vertex has reported positive phase 2b AMPLIFIED results in additional AMKD populations and has completed enrollment in the phase 2/3 AMPLITUDE trial.
APOL1-mediated Kidney Disease | 24/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members